Neogen (NEOG) Stock Price
Neogen Price
Neogen (NEOG) Stock | ISIN US6404911066 | WKN 883297. The current Neogen stock price is 9.16 USD (2026). Revenue is 867.59 M USD. Net income is 64.89 M USD. The P/E ratio is 30.63. Market capitalization is 1.99 B USD. Neogen operates in the Health sector.
Over the last 19 years Neogen grew revenue by 14.1% annually, reaching 894.66 M USD. Earnings per share have grown at 10.4% per year over the last 16 years. For Neogen, the net margin of -122.1% is down versus 13% a few years ago.
Neogen stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Neogen over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Neogen stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Neogen's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Neogen Price |
|---|
Neogen Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Neogen Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (M USD) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (M USD) |
| NET INCOME (M USD) |
| NET INCOME GROWTH (%) |
| SHARES (M) |
| DOCUMENTS |
| 2023 | 2024 | 2025 | 2026e | 2027e | 2028e | 2029e | 2030e |
|---|---|---|---|---|---|---|---|
| 822 | 924 | 894 | 867 | 882 | 890 | 886 | 886 |
| 55.98 | 12.41 | -3.25 | -3.02 | 1.73 | 0.91 | -0.45 | – |
| 49.39 | 50.11 | 47.09 | 48.56 | 47.73 | 47.3 | 47.52 | 47.52 |
| 406 | 463 | 421 | 421 | 421 | 421 | 421 | 421 |
| -22 | -9 | -1,092 | 64 | 73 | 94 | 101 | 101 |
| -145.83 | -59.09 | 12,033.33 | -105.86 | 14.06 | 28.77 | 7.45 | – |
| 188.9 | 216.48 | 216.89 | 216.89 | 216.89 | 216.89 | 216.89 | 216.89 |
| – | – | – | – | – | – | – | – |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Neogen generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Neogen retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Neogen's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Neogen has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Neogen's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Neogen stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Neogen Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Neogen business model & stock analysis
Neogen SWOT Analysis
Strengths
Neogen Corp boasts several key strengths that contribute to its success in the market. Firstly, the company has a strong reputation for producing high-quality and innovative products. This reputation has been built through years of commitment to research and development, resulting in cutting-edge solutions for its customers.
Secondly, Neogen Corp has a diverse product portfolio, spanning multiple industries such as food safety, animal health, and genomics. This diversification mitigates risks associated with relying solely on one market segment and allows Neogen Corp to tap into various revenue streams.
Additionally, the company has a global presence, with operations in multiple countries. This international footprint provides Neogen Corp with access to a broader customer base and market opportunities worldwide.
Weaknesses
Despite its strengths, Neogen Corp also faces certain weaknesses that need to be addressed. One prominent weakness is its heavy dependence on key customers. If a major customer were to reduce its purchases or switch to a competitor, Neogen Corp could experience a significant decline in sales.
Furthermore, Neogen Corp has limited manufacturing capabilities, relying on third-party manufacturers for a portion of its products. This dependence on external vendors introduces potential risks and could impact product availability and quality control.
Opportunities
Neogen Corp can leverage various opportunities to drive growth and expand its market reach. For instance, increasing consumer demand for food safety solutions presents a chance for the company to introduce new products or enhance existing offerings. This trend aligns with Neogen Corp's expertise, giving it a competitive advantage.
Additionally, the growing adoption of genomics and molecular diagnostics provides Neogen Corp with an opportunity to further penetrate the healthcare industry. By investing in research and partnerships, the company can develop advanced genetic testing and diagnostic solutions to meet the evolving needs of the market.
Threats
Neogen Corp faces several threats that could impact its performance and market position. One significant threat is intense competition within its target markets. Competitors may launch similar products or offer competitive pricing, potentially eroding Neogen Corp's market share.
Additionally, regulatory changes and stricter industry standards pose a threat to Neogen Corp's operations. Compliance with evolving regulations requires continuous adaptation and investment in research and development, which may strain the company's resources.
Lastly, economic downturns and fluctuations in exchange rates can negatively affect Neogen Corp's financial performance, particularly in international markets where currency volatility is a concern.
Neogen Segments
Neogen Revenue by Segment (1/4)
3 Years
5 Years
Max
Details
Neogen Revenue by Segment (2/4)
3 Years
5 Years
Max
Details
Neogen Revenue by Segment (3/4)
3 Years
5 Years
10 Years
25 Years
Max
Details
Neogen Revenue by Segment (4/4)
3 Years
5 Years
10 Years
Max
Details
Neogen Revenue by Region
3 Years
5 Years
10 Years
Max
Details
Neogen Eulerpool Fair Value
Neogen historical P/E ratio, EBIT multiple, and P/S ratio
Neogen annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Neogen shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Neogen Earnings Estimates
Neogen Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 4/9/2026 | 0.06USD | 208.58 MUSD | 2026 Q3 |
| 4/1/2026 | 0.06USD | 208.58 MUSD | 2026 Q3 |
| 1/8/2026 | 0.06USD | 212 MUSD | 2026 Q2 |
| 12/17/2024 | 0.1USD | 231.04 MUSD | 2025 Q2 |
| 3/28/2024 | 0.14USD | 240.33 MUSD | 2024 Q3 |
| 1/3/2024 | 0.06USD | 245.37 MUSD | 2024 Q2 |
| 9/26/2023 | 0.13USD | 235.73 MUSD | 2024 Q1 |
| 7/24/2023 | -0.03USD | 250.87 MUSD | 2023 Q4 |
| 3/22/2023 | -0.04USD | 238.77 MUSD | 2023 Q3 |
| 12/19/2022 | -0.08USD | 237.29 MUSD | 2023 Q2 |
EESG©
Eulerpool ESG Scorecard© for the Neogen stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Neogen shareholder structure
| % | Name |
|---|---|
12.70424% | |
10.84969% | |
6.48282% | |
6.45738% | |
5.89868% | |
4.61053% | |
4.33529% | |
4.21083% | |
4.1849% | |
3.96156% |
Neogen Executives and Management Board
Mr. David Naemura
(56)Chief Financial Officer, Chief Operating Officer
Dr. Amy Rocklin
(53)Chief Legal & Compliance Officer
Mr. James Borel
(69)Independent Chairman of the Board
Dr. William Boehm
(77)Independent Director
Dr. Ronald Green
(64)Independent Director
Frequently asked questions about Neogen
Neogen Corp is a leading company in the field of food and animal safety. Their business model revolves around providing diagnostic solutions and expertise to various industries. They offer a wide range of products and services including food safety testing, animal health products, and genomic testing. Neogen Corp utilizes advanced technologies and innovations to ensure the quality and safety of the food supply chain, prevent diseases in animals, and improve overall agricultural productivity. With a strong focus on research and development, Neogen Corp continuously delivers reliable and sustainable solutions to meet the evolving needs of their customers worldwide.
Neogen stock
Neogen Peer Group
Neogen Ticker
Neogen FIGI
All fundamentals and in-depth analysis of Neogen
Our stock analysis for Neogen Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Neogen Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.